Nuveen
SLS icon

Nuveen’s SELLAS Life Sciences SLS Stock Holding History

Nuveen’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.18M Sell
418,729
-252,245
-38% -$1.74M ﹤0.01% 1970
2026
Q1 		$2.84M Sell
670,974
-352,987
-34% -$1.58M ﹤0.01% 2136
2025
Q4 		$3.86M Buy
1,023,961
+26,051
+3% +$50.6K ﹤0.01% 2019
2025
Q3 		$1.61M Buy
997,910
+26,581
+3% +$47.3K ﹤0.01% 2392
2025
Q2 		$2.13M Buy
+971,329
New +$1.49M ﹤0.01% 2277

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Nuveen's SLS Position: Q2 2026 in Review

Nuveen reduced its SELLAS Life Sciences (SLS) stake by 38% in Q2 2026, selling an estimated $1.74M and leaving 418,729 shares worth $6.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1970.

Nuveen first reported a position in SLS in Q2 2025 and has held it in 5 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Nuveen held 418,729 shares of SELLAS Life Sciences worth $6.18M as of Q2 2026.
  • Nuveen sold 252,245 SELLAS Life Sciences shares in Q2 2026, an estimated $1.74M.
  • SELLAS Life Sciences made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1970 holding.
  • Nuveen first reported a position in SELLAS Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.